Pharmacy |
| ||
|
Rosiglitazone Avandia |
|
| ||
Home » Prescription Drugs 14 » Rosiglitazone Avandia Rosiglitazone ((ROS-e-glit-a-zone)) is used to treat a certain type of diabetes mellitus (sugar diabetes) called type 2 diabetes. It may be used alone or with another type of diabetes medicine such as metformin insulin a sulfonylurea or sulfonylurea plus metformin. Rosiglitazone is used for: Controlling blood sugar levels along with diet and exercise in patients with type 2 diabetes. Rosiglitazone is an oral diabetes medicine that help control blood sugar levels. Rosiglitazone is for people with type 2 diabetes who do not use daily insulin injections. This medication is not for treating type 1 diabetes. Rosiglitazone maleate is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. Rosiglitazone is used in the management of type 2 diabetes mellitus (also known as non-insulin-dependent diabetes mellitus [NIDDM] or adult-onset diabetes). Buy Rosiglitazone Avandia and other Prescription Drugs 14 products online at Medstore. 3752
About Rosiglitazone Avandia: Product Type: Prescription Drugs 14 Rosiglitazone ( Avandia Generic Rosiglitazone ) Rosiglitazone (Avandia Generic Rosiglitazone) Avandia Generic Rosiglitazone 4mg Bottle ( 100 Tabs ) Avandia Generic Rosiglitazone Rosiglitazone
View more Prescription Drugs 14 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
